Zoetis Inc.
Market Cap
$53.62B
P/E Ratio
20.18
EPS
$6.03
Dividend Yield
1.67%
52-Week Range
$114.47 — $172.23
Volume
4.50M
Avg Volume
4.51M
Beta
0.95
P/E (TTM)
20.18
Forward P/E
17.68
PEG Ratio
13.17
P/S (TTM)
5.66
P/B (TTM)
16.01
P/FCF
80.50
EV/EBITDA
65.48x
EV/Sales
—
ROE (TTM)
0.58%
ROA (TTM)
0.17%
ROIC
0.07%
Gross Margin
0.70%
Operating Margin
0.38%
Net Margin
0.30%
Debt/Equity
2.85
Current Ratio
3.03
EPS Growth (YoY)
+0.08%
Revenue Growth (YoY)
+0.03%
EPS Growth (3Y)
+0.10%
EPS Growth (5Y)
+0.12%
Sales Growth (3Y)
+0.05%
Sales Growth (5Y)
+0.07%
EPS Est (This Year)
$6.88
EPS Est (Next Year)
$7.48
Dividend Yield
—
Annual Dividend
$0.50
Payout Ratio
0.31%
Frequency
—
Ex-Dividend Date
2025-10-31
Cash/Share
$5.27
Hold
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $141.17(16.0% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
440.69M
Float
439.88M
Free Float %
99.81%
RSI (14)
62.88
SMA 20
$124.91
SMA 50
$124.13
SMA 200
$140.62
ATR (14)
2.89
Volatility (Week)
0.02%
Volatility (Month)
0.01%
Pattern
Inverted Hammer
1 Day
+0.65%
1 Week
+4.67%
1 Month
+0.75%
3 Months
+6.56%
6 Months
-14.02%
1 Year
—
YTD
+1.76%
All-Time High
$177.00
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NYSE
IPO Date
2013-02-01
Employees
13800
CEO
Kristin C. Peck
Index Membership
S&P 500
Website
https://www.zoetis.com
Zoetis Inc. (ZTS) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NYSE. With a market capitalization of $53.62B, a P/E ratio of 20.18, and a dividend yield of 1.67%, ZTS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ZTS against other stocks using dozens of fundamental and technical filters.
Zoetis Inc. (ZTS) has a trailing twelve-month (TTM) P/E ratio of 20.18. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Zoetis Inc. (ZTS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Zoetis Inc. (ZTS) has a market capitalization of $53.62 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Hold" rating on Zoetis Inc. (ZTS) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $141.17 implies 16.0% upside from the current price.
Zoetis Inc. (ZTS) has returned +1.76% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.